Shows
Inercia Cero: Corazón, Riñón y MetabolismoAnemia en ERC (KDIGO 2026)ESA = Erythropoiesis-Stimulating AgentInstagram: @dr.gilbertogarciabernalInfografías en X: @DoctorGilbertoGKDIGO 2026 Clinical Practice Guideline for the Management of Anemia in Chronic Kidney Disease (CKD) (Kidney Int., 2026) Esta guía actualiza las pautas para la evaluación y el manejo de la anemia en pacientes adultos y pediátricos con enfermedad renal crónica, incluyendo a receptores de trasplante y pacientes en diálisis. El documento introduce una nueva nomenclatura para la deficiencia de hierro y ofrece recomendacio...
2026-02-1116 min
The FCP PodcastRenal Function Interpretation with Dr Dabasish Banerjee Episode 1 - PotassiumSend us a textRichard is joined by renal consultant Dr Dabashish Banerjee to break down the interpretation of renal function tests — without the nephrology-induced headache.In this episode, we explore when renal function tests should be requested, what they actually include, and how to interpret results confidently in clinical practice.The conversation then focuses on potassium disorders, using real-world cases to unpack hypokalemia and hyperkalemia. We discuss key history points, relevant investigations, red flags not to miss, and when referral....
2026-02-0658 min
ER/ICU RadioCKD１．論文のタイトルChronic kidney disease２．CitationLancet 2026; 407: 90–104３．論文内容のまとめ慢性腎臓病（CKD）は、腎臓の構造または機能の異常が3か月以上持続し、健康に影響を及ぼす状態と定義されます。世界全体で約8億5000万人の患者がいると推定され、2050年までに世界の死因の第5位になると予測されています。CKD患者は腎不全に至るリスクだけでなく、心血管疾患の発症やそれによる早期死亡のリスクが非常に高いことが特徴です。診断とステージングには、血清クレアチニンやシスタチンCから算出される推算糸球体濾過量（eGFR）と、尿中アルブミン・クレアチニン比（uACR）という簡便な検査が用いられます。KDIGO（腎臓病：改善すべき世界的予後）は、原因（C）、GFR区分（G）、アルブミン尿区分（A）に基づくCGA分類を推奨しています。治療面では、2019年以降の臨床試験により、腎機能の低下を抑え心血管リスクを軽減する効果的な薬物療法が確立されました。現在の標準治療として推奨される「4つの核心的な介入」は、SGLT2阻害薬、RAS阻害薬（ACE阻害薬またはARB）、スタチン、および厳格な血圧管理（130/80 mmHg未満、容認されれば収縮期120 mmHg未満）です。さらに、2型糖尿病を合併するCKD患者には、GLP-1受容体作動薬（セマグルチドなど）や非ステロイド型ミネラルコルチコイド受容体拮抗薬（フィネレノン）の併用が検討されます。世界保健機関（WHO）は2025年に腎臓の健康推進に関する決議を採択しており、低・中所得国を含む世界中での早期発見と、費用対効果の高い治療の普及が、CKDによる世界的な負担を軽減するために不可欠であるとされています。４．批判的吟味内的妥当性本論文は「Seminar」という形式の総説であり、MEDLINEを用いた広範な文献検索に基づいています。特に、KDIGOなどの国際的な診療ガイドラインや、直近5年間に発表された影響力の高いランダム化比較試験（RCT）、メタ解析の結果を統合して構成されています。著者はKDIGOの共同議長を含む専門家であり、エビデンスの解釈の信頼性は高いと考えられます。一方で、系統的レビュー（Systematic Review）のような厳密な手法による網羅的なデータ統合ではないため、選択された文献のバイアスの影響を完全に排除することは困難です。外的妥当性本論文で示された治療戦略は、多くの大規模RCT（EMPA-KIDNEY、FLOW試験など）に基づいているため、一般的なCKD患者に対する普遍性は高いと言えます。しかし、低所得国における透析や移植といった腎代替療法のアクセスには依然として大きな格差があることが指摘されています。また、SGLT2阻害薬やGLP-1受容体作動薬などの最新治療の費用対効果は地域によって異なる可能性があり、すべての医療資源設定において即座に同じ基準のケアを提供できるわけではないという現実的な制約も考慮する必要があります。
2026-02-0416 min
NefropapersVideocast 17 - Anemia na DRC | KDIGO 2026Anemia na Doença Renal Crônica (DRC) não é “só um número”: impacta fadiga, qualidade de vida, capacidade funcional e desfechos cardiovasculares. Neste videocast, o Dr. Igor Pietrobom, a Dra. Maria Estela e Dra. Raquel Sogaiar, trazem os principais pontos do KDIGO 2026 para anemia na DRC: definição operacional, como investigar causas além da “anemia renal”, o protagonismo do ferro (e a nova nomenclatura), além de como pensar em ESA, transfusão e o papel dos estabilizadores da HIF (HIF-PHI).🔹Siga nosso canal para não perder os próximos ep...
2026-01-2353 min
KDIGO Conversations in NephrologyEpisode 30: Challenges of Implementing Evidence-Based Guidance for IgA NephropathyThis final episode in KDIGO’s four-part IgAN series focuses on the challenges and opportunities of implementing the updated KDIGO IgAN Guideline in clinical practice. The conversation examines a shifting treatment paradigm that emphasizes earlier intervention and simultaneous, multi-targeted therapy, while addressing persistent barriers to guideline adoption, including gaps in disease awareness, diagnostic precision, and risk stratification. Drawing on insights from recent clinical trials, the discussion also explores how emerging evidence is shaping therapeutic decision-making, highlights priority areas for future IgAN research, and considers what continued innovation may mean for improving long-term patient outcomes....
2025-12-1818 min
KDIGO Conversations in NephrologyEpisode 29: How I Treat IgAN: Lessons from the Case FilesThis third episode in KDIGO’s four-part IgAN series explores how to apply KDIGO guidance in real-world IgAN care through two illustrative patient cases. Building on earlier episodes in the series, the discussion highlights dynamic risk assessment, treatment selection, and monitoring strategies, along with practical decisions about RAS inhibitors versus DEARAs, TRF-budesonide versus systemic glucocorticoids, and the use of SGLT2 inhibitors. The episode also addresses complex scenarios, including rapidly progressive glomerulonephritis, nephrotic syndrome, acute kidney injury, pediatric IgAN, pregnancy, and treatment considerations in resource-limited settings. The episode is hosted by Dana Rizk, MD (University of Alabama at Bir...
2025-12-0420 min
Unscripted - The AMCP PodcastEp. 45 – Understanding IgA Nephropathy and the New 2025 KDIGO GuidelinesIn this episode of Unscripted, we speak with Dr. Kartik Kalra, Clinical Nephrologist at Geisinger Medical Center. We discuss IgA nephropathy and the newly released, comprehensive 2025 KDIGO guidelines. We explore what IgAN is, why diagnosis is often delayed, how it commonly presents, and the impact the disease can have over a patient’s lifetime. Dr. Kalra also discusses what prompted the latest guideline revision, how thinking around IgAN has evolved, and what these changes signal for clinicians, health systems, and the managed care community. This podcast is supported by an independent medical education grant from Calliditas Therapeutics. AMCP offers CP...
2025-11-2111 min
ReachMD CMEIgAN Management Into Practice: Evolving Guidelines & Targeted TherapiesCME credits: 0.25
Valid until: 19-11-2026
Claim your CME credit at https://reachmd.com/programs/cme/igan-management-into-practice-evolving-guidelines-targeted-therapies/37238/
Dr. Jürgen Floege, co-chair of the KDIGO Work Group, and Dr. Jörg Latus review the updated KDIGO 2025 guidelines for managing immunoglobulin A nephropathy (IgAN) and IgA vasculitis (IgAV), which emphasize diagnostic criteria, proteinuria-based treatment thresholds, and revised therapeutic goals. The discussion focuses on the new KDIGO proteinuria treatment goal of
2025-11-1914 minCME/CEIgAN Management Into Practice: Evolving Guidelines & Targeted Therapies
Faculty: Jörg Latus, MD
Faculty: Jürgen Floege, MD
Dr. Jürgen Floege, co-chair of the KDIGO Work Group, and Dr. Jörg Latus review the updated KDIGO 2025 guidelines for managing immunoglobulin A nephropathy (IgAN) and IgA vasculitis (IgAV), which emphasize diagnostic criteria, proteinuria-based treatment thresholds, and revised therapeutic goals. The discussion focuses on the new KDIGO proteinuria treatment goal of
2025-11-1914 minCMEIgAN Management Into Practice: Evolving Guidelines & Targeted Therapies
Faculty: Jörg Latus, MD
Faculty: Jürgen Floege, MD
Dr. Jürgen Floege, co-chair of the KDIGO Work Group, and Dr. Jörg Latus review the updated KDIGO 2025 guidelines for managing immunoglobulin A nephropathy (IgAN) and IgA vasculitis (IgAV), which emphasize diagnostic criteria, proteinuria-based treatment thresholds, and revised therapeutic goals. The discussion focuses on the new KDIGO proteinuria treatment goal of
2025-11-1914 minReachMD CMEIgAN Management Into Practice: Evolving Guidelines & Targeted TherapiesCME credits: 0.25
Valid until: 19-11-2026
Claim your CME credit at https://reachmd.com/programs/cme/igan-management-into-practice-evolving-guidelines-targeted-therapies/37238/
Dr. Jürgen Floege, co-chair of the KDIGO Work Group, and Dr. Jörg Latus review the updated KDIGO 2025 guidelines for managing immunoglobulin A nephropathy (IgAN) and IgA vasculitis (IgAV), which emphasize diagnostic criteria, proteinuria-based treatment thresholds, and revised therapeutic goals. The discussion focuses on the new KDIGO proteinuria treatment goal of
2025-11-1914 minCMEIgAN Management Into Practice: Evolving Guidelines & Targeted Therapies
Faculty: Jörg Latus, MD
Faculty: Jürgen Floege, MD
Dr. Jürgen Floege, co-chair of the KDIGO Work Group, and Dr. Jörg Latus review the updated KDIGO 2025 guidelines for managing immunoglobulin A nephropathy (IgAN) and IgA vasculitis (IgAV), which emphasize diagnostic criteria, proteinuria-based treatment thresholds, and revised therapeutic goals. The discussion focuses on the new KDIGO proteinuria treatment goal of
2025-11-1914 min
KDIGO Conversations in NephrologyEpisode 28: APOL1 Screening and Early Detection - Patient and Clinician PerspectivesIn the final episode of KDIGO’s three-part Conversations in Nephrology series on APOL1 kidney disease, host Kirk Campbell, MD (University of Pennsylvania, United States), speaks with Titilayo Ilori, MD (Boston University, United States), and kidney health advocate Joshua Albright (United States) about how APOL1 genetic testing can shape the future of kidney care. Their conversation brings together clinical expertise and lived experience to examine why early detection matters, how to overcome barriers to equitable testing, and what it will take to turn awareness into meaningful action for patients and communities.Learn more and access resources from th...
2025-10-2813 min
KDIGO Conversations in NephrologyEpisode 27: Management of Patients with APOL1 Kidney DiseaseIn this second installment of KDIGO’s three-part podcast series on APOL1 kidney disease, host Kirk Campbell, MD (University of Pennsylvania, United States), welcomes Barry Freedman, MD (Wake Forest University School of Medicine, United States) for a practical discussion on patient management. They examine how APOL1 risk variants influence progression, review current therapeutic approaches, and explore emerging targeted treatments designed to improve care and outcomes for affected individuals.Learn more and access resources from the KDIGO Controversies Conference on APOL1 Kidney Disease: https://kdigo.org/conferences/apol1-kidney-disease/This podcast wa...
2025-10-2819 min
KDIGO Conversations in NephrologyEpisode 26: Burden and Pathophysiology of APOL1 Kidney DiseaseThis is the first episode of a three-part KDIGO Conversations in Nephrology series on APOL1 kidney disease. Host Kirk Campbell, MD (University of Pennsylvania, United States), speaks with Bessie Young, MD (University of Washington, United States) about the discovery, burden, and biology of APOL1 kidney disease. Their discussion explores how APOL1 variants contribute to increased kidney disease risk in people of African ancestry, recent findings on protective variants, and ongoing research toward targeted therapies.Learn more and access resources from the KDIGO Controversies Conference on APOL1 Kidney Disease: https://kdigo.org/conferences/apol1-kidney-disease/
2025-10-2813 min
Hospital Medicine UnpluggedContrast-Induced Nephropathy in Hospitalized Patients: KDIGO Guidelines, Dual Mechanism Injury, and Essential Prevention ProtocolsIn this episode of Hospital Medicine Unplugged, we unpack contrast-induced nephropathy (CIN)—spot the risks, flood the kidneys (not the lungs), cut the contrast, and prevent a hospital-acquired AKI before it starts.
We open with the do-firsts: identify high-risk inpatients—those with CKD (especially eGFR
2025-10-1429 minNefropapersVideocast 11 - KDIGO IgA 2025: O que muda no diagnóstico e tratamento da nefropatia por IgAO novo guideline KDIGO IgA traz recomendações que impactam diretamente a rotina do nefrologista no manejo da nefropatia por IgA.Neste episódio, Gabriel Montezuma, Igor Pietrobom e Maria Eduarda Vilanova discutem:✔️ Quando indicar biópsia renal e por que biopsiar mais cedo pode mudar o tratamento✔️ Como aplicar o MEST-C e escores prognósticos na prática clínica✔️ Diferenças entre guideline e vida real no manejo da NIgA✔️ Estratégias de nefroproteção: ordem de início e combinações✔️ Papel da imunossup...
2025-10-021h 13
KDIGO Conversations in NephrologyEpisode 25: Treatment Revolution in IgA NephropathyThis second episode in KDIGO’s four-part IgAN series addresses the treatment revolution in IgAN. Join Dana Rizk, MD (University of Alabama at Birmingham, US), and Shikha Wadhwani, MD (University of Texas Medical Branch, US) in understanding how disease pathophysiology is fueling a wave of new therapies that go beyond traditional supportive care. Key topics include what's changed since the KDIGO 2021 Guideline, the four-hit hypothesis and its role in driving novel therapies, key factors to consider when selecting treatments, and the evolving role of traditional approaches alongside newer agents.Th...
2025-10-0214 min
KDIGO Conversations in NephrologyEpisode 24: Overview of the Latest Guidance in IgA Nephropathy ManagementThis is the first episode in KDIGO's four-part series on the KDIGO 2025 IgAN/IgAV Guideline. Join Dana Rizk, MD (University of Alabama at Birmingham, United States), and Brad Rovin, MD (Ohio State University, United States), Co-Chair of the 2025 KDIGO IgAN Guideline, for a deep dive into the latest updates in patient care. Their conversation explores the key takeaways from the new guideline, the critical role of kidney biopsies in diagnosis and prognosis, the use of the IgAN prediction tool for risk assessment, and the updated thresholds and treatment goals aimed at improving outcomes.Future...
2025-10-0219 minNefropapersVideocast 11 - KDIGO IgA 2025: O que muda no diagnóstico e tratamento da nefropatia por IgAO novo guideline KDIGO IgA traz recomendações que impactam diretamente a rotina do nefrologista no manejo da nefropatia por IgA.Neste episódio, Gabriel Montezuma, Igor Pietrobom e Maria Eduarda Vilanova discutem:✔️ Quando indicar biópsia renal e por que biopsiar mais cedo pode mudar o tratamento✔️ Como aplicar o MEST-C e escores prognósticos na prática clínica✔️ Diferenças entre guideline e vida real no manejo da NIgA✔️ Estratégias de nefroproteção: ordem de início e combinações✔️ Papel da imunossupressão, incluind...
2025-10-021h 10
Nutrition.Sport.Health by Arthur DelcourtProtéger ses reins via l'alimentation- Viridiana grillo, RD (GDN- Les diététiciens-UPDLF)Bonjour à toutes et tous, le podcast NSH lance sa nouvelle saison avec ce première épisode en compagnie de Viridiana Grillo- diététicienne spécialisé en néphrologie (GDN-Les diététiciens, UPDLF) et chef de section diététique à la Haute école Vinci à Bruxelles- pour aborder l'importance d'avoir une bonne alimentation pour protéger ses reins que l'on soit en bonne santé ou atteints d'une pathologie rénale. N'hésitez pas à liker, commenter, partager et bien sûr vous abonner au podcast pour me soutenir gratuitement. Cela me motive à vous sortir plus d'épisode avec des experts reconnus dans le monde...
2025-09-2325 min
KDIGO Conversations in NephrologyEpisode 23: A Patient and Caregiver PerspectiveWhat does life with a rare kidney disease really look like?Marianne Silkjaer Nielsen (Founder of CompCure, Denmark) offers a powerful voice for patients and caregivers. She reflects on the long diagnostic journey, the challenges of managing rare kidney disease, and the need for better awareness, advocacy, and international registries to improve outcomes.This episode is part of a four-part KDIGO Conversations in Nephrology series on complement-mediated kidney diseases, hosted by Dr. Carla Nester (University of Iowa Stead Family Children’s Hospital, United States).Th...
2025-09-0312 min
KDIGO Conversations in NephrologyEpisode 22: Advancing Research and Novel Therapies for C3GWhat does the future of treatment for C3 Glomerulopathy (C3G) look like? Dr. Nicole van de Kar (Radboud University Medical Center, The Netherlands) unpacks the pathophysiology of C3G, from genetic and autoantibody factors to the central role of the alternative pathway. She explores the limits of current C5 therapies and the potential of new strategies targeting C3 activation that could reshape patient care worldwide. This episode is part of a four-part KDIGO Conversations in Nephrology series on complement-mediated kidney diseases, hosted by Dr. Carla Nester (University of...
2025-09-0323 min
KDIGO Conversations in NephrologyEpisode 21: Diagnosis and Management of C3GHow do patients with C3 Glomerulopathy (C3G) present, and why is confirming the diagnosis so complex? Dr. David Kavanagh (National Renal Complement Therapeutics Centre, United Kingdom) walks through the diagnostic process, the shortcomings of traditional immunosuppression, and the promise of emerging therapies like alternative pathway inhibitors. He also tackles one of the toughest challenges: managing post-transplant recurrence.This episode is part of a four-part KDIGO Conversations in Nephrology series on complement-mediated kidney diseases, hosted by Dr. Carla Nester (University of Iowa Stead Family Children’s Hospital, United States)....
2025-09-0315 min
KDIGO Conversations in NephrologyEpisode 20: The Role of Complement in Kidney DiseasesWhy does it matter if a kidney disease is complement-driven or complement-associated? Dr. Matthew Pickering (Imperial College London, United Kingdom) explains this critical distinction and why it changes how clinicians approach diagnosis and treatment. The discussion explores promising new therapies such as C3 and C5 inhibitors and how biomarkers are paving the way for precision medicine in nephrology. This episode is part of a four-part KDIGO Conversations in Nephrology series on complement-mediated kidney diseases, hosted by Dr. Carla Nester (University of Iowa Stead Family Children’s Hospital, United States)....
2025-09-0319 min
Ta de ClinicagemTdC 298: Doença renal crônica - Atualização KDIGOhttps://www.tadeclinicagem.com.br/materiais/evento-org-dzero-na-residencia-2026/O começo do R1 de Clínica Médica pode ser desafiador. Mas você não precisa passar por isso sozinho(a).Descubra como tornar o R1 mais leve e produtivo com o D0 na Residência, evento on-line e gratuito do TdC.Garanta agora mesmo sua vaga e receba grátis no seu e-mail o Ebook: Sala de Emergência - Temas Essenciais.Do manejo de antibióticos à organização da rotina com IA, confira os temas que abordaremos ao vivo Sábado...
2025-08-2846 min
Afya PodcastsCheck-up Semanal #212: Novas diretrizes KDIGO para síndrome nefrótica em crianças; Afuresertib no câncer de ovário resistente à platina e mais!Confira os temas do Check-up Semanal de hoje: Cirurgia minimamente invasiva para tumores neuroendócrinos pancreáticos não funcionantes: qual a vantagem real?; Novas diretrizes KDIGO para síndrome nefrótica em crianças; Afuresertib no câncer de ovário resistente à platina: o que dizem os resultados?; Lepodisiran e a redução de lipoproteína(a); Uma revisão completa sobre dedo em martelo. Aperte o play e ouça agora!
2025-08-1309 min
Medicina del LaboratorioIA 6: Resumen Guía KDIGO 2025En este episodio se resumen los detalles de las pruebas de laboratorio recomendadas por la guia KDIGO 2025.
2025-06-2909 min
The Rounds TableEpisode 124 - 2024 KDIGO Clinical Practice Guidelines for Chronic Kidney DiseaseSend us a textWelcome back Rounds Table Listeners! Today we have the next episode in our Clinical Practice Guidelines series. Drs. Mike and John Fralick discuss the top takeaways from the 2024 KDIGO Clinical Practice Guidelines for chronic kidney disease. Here we go!1. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (0:00 - 24:24)Access the KDIGO 2024 "Top 10 Takeaways" PDFs here: https://kdigo.org/guidelines/ckd-evaluation-and-management/The Good Stuff:Nephrology Trial Files - https://nephrotrialfiles.substack.com/ (24:25 - 24:48)The Phoenician Scheme (24:49 - 25:33)Questions? Comments? Feedback? We’d l...
2025-06-2625 minThe Rounds TableEpisode 124 - 2024 KDIGO Clinical Practice Guidelines for Chronic Kidney DiseaseSend us a textWelcome back Rounds Table Listeners! Today we have the next episode in our Clinical Practice Guidelines series. Drs. Mike and John Fralick discuss the top takeaways from the 2024 KDIGO Clinical Practice Guidelines for chronic kidney disease. Here we go!1. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (0:00 - 24:24)Access the KDIGO 2024 "Top 10 Takeaways" PDFs here: https://kdigo.org/guidelines/ckd-evaluation-and-management/The Good Stuff:Nephrology Trial Files - https://nephrotrialfiles.substack.com/ (24:25 - 24:48)The Phoenician Scheme (24:49 - 25:33)Questions? Comments? Feedback? We’d l...
2025-06-2625 min
Freely Filtered, a NephJC PodcastFF 80 KDIGO ADPKD Guideline DraftThe FiltrateJoel TopfAC GomezSophia AmbrusoNayan AroraSpecial Guest Charles Edelstein, MD, PhD Professor, Medicine-Renal Med Diseases/HypertensionExtra-Special GuestMichelle Rheault, MD Professor of Pediatrics, University of MinnesotaEditing bySimon and Joel TopfThe Kidney Connection written and performed by by Tim YauShow NotesKDIGO ADPKD Guidelines:WebsiteGuideline PDFExecutive Summary PDFNephJC coverage...
2025-05-131h 18
Afya PodcastsCheck-up Semanal #212: Novas diretrizes KDIGO para síndrome nefrótica em crianças; Afuresertib no câncer de ovário resistente à platina e maConfira os temas do Check-up Semanal de hoje: Cirurgia minimamente invasiva para tumores neuroendócrinos pancreáticos não funcionantes: qual a vantagem real?; Novas diretrizes KDIGO para síndrome nefrótica em crianças; Afuresertib no câncer de ovário resistente à platina: o que dizem os resultados?; Lepodisiran e a redução de lipoproteína(a); Uma revisão completa sobre dedo em martelo. Aperte o play e ouça agora!
2025-05-1209 min
Life as a Nephrology ProfessionalCKD MBD in 2025: Updates from KDIGOIn this episode of Life as a Nephrology Professional, host, Raphy Rosen is joined once again by Thomas L. Nickolas to continue to discuss the world of CKD MBD. They explore KDIGO's update from the recent controversies conference and unpack the publication from Kidney International. Don't miss their past episode with Dr. Sharon Moe and Dr. Harold Rosen, published in January 2025.
Host: Raphy Rosen, MD, FASN, FNKF
Guests: Thomas L. Nickolas MD, MS
2025-03-1319 minNefropapersVideocast 4 - Novidades do KDIGO de DRPAD (Doença Renal Policística Autossômica Dominante)Os guidelines do KDIGO são as principais recomendações da nefrologia mundial.
Doença Renal Policística Dominante é a principal doença genética monogênica que leva à DRC.
Nesse videocast, Layon, Igor e Maria Amélia abordam os principais pontos do tão esperado KDIGO de DRPAD.
2025-02-2046 min
Healthier World with Quest Diagnostics09 - Instant insights: Kidney Profile and eGFR with Creatinine and Cystatin-C (7 min)1in 7 US adults are estimated to have chronic kidney disease, or CKD. Because early stages of the disease are often clinically silent, 90% of individuals with CKD don’t know they have it. This podcast highlights the importance of early CKD detection and the need for proper screening, especially in individuals with hypertension and diabetes. The Kidney Profile aligns with guidelines and includes the urine-albumin-creatinine ratio and eGFR. The new 2024 guidelines recommend using both creatinine and Cystatin C in estimating eGFR in certain populations, which provides a more accurate risk assessment for CKD and other cardiometabolic conditions like heart disease an...
2025-01-0306 min
Life as a Nephrology ProfessionalKDOQI Commentary on the KDIGO Clinical Practice Guideline for the Evaluation and Management of CKDDiscover the latest updates in kidney care with an in-depth look at the KDOQI Commentary on the 2024 KDIGO Clinical Practice Guideline for CKD. This episode unpacks groundbreaking advancements, including new strategies for albuminuria testing, the adoption of novel cardio-kidney protective agents, updated dietary and medication recommendations, and innovative approaches to improving care delivery. Gain actionable insights on implementing these guidelines and enhancing patient outcomes through interdisciplinary care. Don’t miss this essential listen for kidney health professionals striving to stay ahead in CKD management!
Host: Anna Gaddy, MD, FASN, FNKF
Guests: Michelle Estrella, MD, MHS; Sank...
2024-12-1940 minNefropapersEpisódio 92 - KDIGO 2024 de Nefropatia por IgASaiu!!
Quase tão aguardado quanto o próprio guideline do KDIGO (com perdão pela hipérbole...ahahah), finalmente saiu nosso episódio sobre o KDIGO de NIgA!! Em setembro foi publicada a versão draft - provisória, mas que já traz bastante material para abrirmos diversas discussões interessantes para ajudar no manejo dos nossos pacientes!
Gabs faz uma discussão com ele mesmo nesse episódio solo dos diversos pontos cruciais de mudanças e controvérsias desse KDIGO, como momento para biópsia, alvo de tratamento, indicação e forma de fazer nefropr...
2024-10-2424 min
Freely Filtered, a NephJC PodcastFF 74: Amino Acids for AKIThe Filtrate:Jennie LinJoel TopfJosh WaitzmanSwapnil HiremathWith Special GuestsPedro TeixeiraJay KoynerEditor Sophia AmbrusoShow NotesThe article: A Randomized Trial of Intravenous Amino Acids for Kidney ProtectionNephJC SummaryKDIGO Clinical Practice Guideline for Acute Kidney Injury (PDF)Steve Coca study Evaluation of Short-Term Changes in Serum Creatinine Level as a Meaningful End Point in Randomized Clinical Trials (PubMed)Using Nephrocheck to...
2024-10-191h 32
The Kidney Chronicles: A Pediatric Nephrology PodcastEpisode 31: Genetic TestingDr. Matthew Sampson, a pediatric nephrologist and associate professor of pediatrics at Harvard Medical School, walks us through genetic testing for pediatric patients with kidney disease. He discusses indications for genetic testing and how to interpret results. He also talks about his lab and work as a genomics researcher.
Episode References
Sampson Lab: https://www.sampsonlab.org/
ClinVar: https://www.ncbi.nlm.nih.gov/clinvar/
KDIGO genetic testing guidelines: https://kdigo.org/wp-content/uploads/2022/05/KDIGO-Genetics-in-CKD-Conference-Report-Corrected-Proof.pdf
NKF genetic testing guidelines: https://www.ajkd.org/article/S0272-6386(24)00871-0/fulltext
CJASN Genomics of Kidney Disease Series: https://journa...
2024-10-071h 01
SBN PodcastsNova era no manejo do renal crônico. O que aprendemos com as Atualizações KDIGO 2024? (SBN#70)Queridos ouvintes, sejam bem-vindos ao Podcast: Nova era no manejo do renal crônico. O que aprendemos com as Atualizações KDIGO 2024?
Lembre-se: Beba água e dose sua creatinina!
Produção Geral: SBN Edição: Mapa Mundi
Moderador: Lucas Luz
Entrevistados: Ana Flávia Moura, José Neto, Eduardo Rocha
Apoio: AstraZeneca
2024-10-0450 min
Behind The Knife: The Surgery PodcastMedicine Consult Series: Ep. 3 - Acute Kidney InjuryLow urine output – when is it a cause for alarm? Emma Burke is joined by Dr. Bryan Tucker to discuss quick hits on acute kidney injury as part of the Med/Surg Consult series.
Host:
- Emma Burke, MD – General Surgery Resident at Baylor College of Medicine, @emmaburke017
Guest:
- Bryan Tucker, DO – Nephrologist at Baylor College of Medicine, @bmtucker3
Learning Objectives:
- Define acute kidney injury (AKI) using KDIGO guidelines.
- Develop a framework for initial workup of perioperative AKI.
- Discuss the importance of in urine output in AKI...
2024-09-2317 min
GN in TenBoard Review Bonus #2: Minimal Change DiseaseIn this special bonus episode of the podcast, Koyal and Kenar provide a maximally useful review of minimal change disease, from diagnosis (including secondary causes to screen for) to treatment options, including how to decide which patients may do better with which therapies. Can’t get enough minimal change? Check out Episode 6 (with Astrid Weins) and Episode 7 (with Felicitas Hengel and Nicola Tomas) for more on the potential role of anti-nephrin autoantibodies in MCD.ReferencesKDIGO guidelines: https://kdigo.org/wp-content/uploads/2017/02/KDIGO-GD-Guideline-Key-Takeaways-for-Clinicians-Minimal-Change-Disease.pdfAnt...
2024-09-1624 min
Der Springer Medizin PodcastNeuerungen der KDIGO-Leitlinie zur CKD (mit freundlicher Unterstützung von Boehringer Ingelheim und Lilly Deutschland)mit Dr. Daniel Kitterer, Facharzt für Innere Medizin und Nephrologie im Internistisch-Hausärztlichen-Zentrum Grafenau
Die Leitlinien der KDIGO wurden im April 2024 das erste Mal seit 12 Jahren aktualisiert. Die KDIGO, „Kidney Disease – Improving Global Outcomes“, ist eine internationale unabhängige gemeinnützige Organisation, deren Ziel es ist, weltweit die Behandlung von Patientinnen und Patienten mit Nierenkrankheiten zu verbessern. Sie koordiniert die Entwicklung von evidenzbasierten klinischen nephrologischen Leitlinien. Die aktualisierten Leitlinien zur Therapie der chronischen Niereninsuffizienz geben eine wichtige Orientierung, um Therapieentscheidungen für Patientinnen und Patienten mit chronischer Niereninsuffizienz – CKD – zu treffen, die Nierenfunktion zu stabilisieren und ein Nierenversagen nach Möglichkei...
2024-09-1014 min
ÄrzteTag extraNeuerungen der KDIGO-Leitlinie zur chronischen NiereninsuffizienzMit freundlicher Unterstützung von Boehringer Ingelheim und Lilly Deutschland
Die Leitlinien der KDIGO wurden im April 2024 das erste Mal seit 12 Jahren aktualisiert. Die KDIGO, „Kidney Disease – Improving Global Outcomes“, ist eine internationale unabhängige gemeinnützige Organisation, deren Ziel es ist, weltweit die Behandlung von Patientinnen und Patienten mit Nierenkrankheiten zu verbessern. Sie koordiniert die Entwicklung von evidenzbasierten klinischen nephrologischen Leitlinien. Die aktualisierten Leitlinien zur Therapie der chronischen Niereninsuffizienz geben eine wichtige Orientierung, um Therapieentscheidungen für Patientinnen und Patienten mit chronischer Niereninsuffizienz – CKD – zu treffen, die Nierenfunktion zu stabilisieren und ein Nierenversagen nach Möglichkeit zu verhindern.
Dr. Danie...
2024-09-1013 minNefropapersVideocast 2 - Novidades do KDIGO 2024 de DRCVenha conferir as principais novidades que as atualizações do KDIGO de 2024 nos trouxe na Doença Renal Crônica!
2024-09-051h 17
Freely Filtered, a NephJC PodcastFF 73: The KDIGO 2024 CKD Guideline DraftThe draft order:Sophia AmbrusoNayan AroraSwapnil HiremathAC GomezJoel TopfEditor Nayan AroraShow NotesPrevious drafts:2021 KDIGO Hypertension —Joel, Sophia, Swap, Nayan, Josh2021 ASN Kidney Week Draft—Joel, Sophia, Swap, Nayan, Jennie2022 The ISPD Peritonitis Guideline— Joel, Sophia, Swap, Nayan2022 ASN Kidney Week Draft—Joel, Sophia, Swap, Nayan2023 ASN Kidney Week Draft—Joel, Sophia, Swap, Nayan, AC, Josh2024 KDIGO CKD Clinical Practice Guideline —Joel, Sophia, Swap, Nayan...
2024-08-011h 32
Ta de ClinicagemTdC 240: Primeira consulta na Doença Renal Crônicahttps://www.tadeclinicagem.com.br/materiais/evento-org-dzero-na-residencia-2026/O começo do R1 de Clínica Médica pode ser desafiador. Mas você não precisa passar por isso sozinho(a).Descubra como tornar o R1 mais leve e produtivo com o D0 na Residência, evento on-line e gratuito do TdC.Garanta agora mesmo sua vaga e receba grátis no seu e-mail o Ebook: Sala de Emergência - Temas Essenciais.Do manejo de antibióticos à organização da rotina com IA, confira os temas que abordaremos ao vivo Sábado...
2024-06-2758 min
在家也藥知道糖尿病腎病變治療藥物新進展留言告訴我你對這一集的想法： https://open.firstory.me/user/cl46mafq1001u01zg25tv0l6x/comments DKD是一種嚴重且常見的糖尿病併發症，對患者的預後有重大影響。透過控制血糖、血壓和血脂，以及使用有效的藥物治療，可以顯著延緩病程進展。目前已有多種藥物在DKD的治療中顯示出良好的效果。藉由這些新進展，我們對於DKD的治療將有更多的選擇和希望，進一步改善患者的生活品質和長期預後。 作者：林奕瑱藥師（社團法人台灣家庭藥師學會） 台灣家庭藥師學會官網: https://familypharm.org/ 台灣家庭藥師學會臉書: https://www.facebook.com/profile.php id=100067147454610&mibextid=LQQJ4d 文獻來源: 1. Wang JS, Yen FS, Lin KD, Shin SJ, Hsu YH, Hsu CC; Diabetes Kidney Disease Research Committee of the Diabetes Association of the Republic of China (Taiwan). Epidemiological characteristics of diabetic kidney disease in Taiwan. J Diabetes Investig. 2021 Dec;12(12):2112-2123. doi: 10.1111/jdi.13668. Epub 2021 Oct 3. PMID: 34529360; PMCID: PMC8668071. 2. Nikolaus Marx, Massimo Federici, Katharina Schütt, Dirk Müller-Wieland, Ramzi A Ajjan, Manuel J Antunes, Ruxandra M Christodorescu, Carolyn Crawford, Emanuele Di Angelantonio, Björn Eliasson, Christine Espinola-Klein, Laurent Fauchier, Martin Halle, William G Herrington, Alexandra Kautzky-Willer, Ekaterini Lambrinou, Maciej Lesiak, Maddalena Lettino, Darren K McGuire, Wilfried Mullens, Bianca Rocca, Naveed Sattar, ESC Scientific Document Group , 2023 ESC Guidelines for the mana...
2024-06-2605 min
What's it Worth? A Journal Club PodcastS2E3 (#14) - Can I Have Some More Power Please? Apixaban vs Warfarin for AFib in HemodialysisWelcome back to What's it Worth! Join your hosts, Dr. Diana Langworthy and P4 Garrison Avery, as we discuss the RENAL-AF trial comparing apixaban vs warfarin in hemodialysis patients. These authors aimed to assess safety and efficacy in one of the first prospective trials comparing DOACs with warfarin in hemodialysis patients. Ever read a trial that didn't enroll their goal number of patients? Let's dig into patient recruitment considerations in trials and also pragmatic applications to medication selection, and properties of drugs that can be cleared by hemodialysis with real pharmacokinetic data to support! Key Points...
2024-05-0636 min
KDIGO Conversations in NephrologyEpisode 19: Extracorporeal Blood Purification in the Context of Multiorgan Support: Current Role and Best PracticesEpisode 19 is the third episode in KDIGO's three-episode series on acute kidney injury (AKI), hosted by Dr. Kathleen Liu (University of California at San Francisco, United States).
In this episode, Dr. Liu and Dr. Claudio Ronco (International Renal Research Institute of San Bortolo Hospital, Italy) discuss recent advancements and best practices surrounding Extracorporeal Blood Purification within the complex scenario of multiorgan support. This thought-provoking discussion, explores:
Recent clinical trials suggesting minimal benefits of early CRRT in AKI for critically ill patients. The conversation delves into whether these findings translate to patients experiencing multiorgan failure, exploring...
2024-03-2111 min
KDIGO Conversations in NephrologyEpisode 18: Personalized Care for AKI – The Role of Digital Decision Support Tools and Augmented Human Intelligence to Improve Outcomes in AKIEpisode 18 is the second episode in KDIGO's three-episode series on acute kidney injury (AKI), hosted by Dr. Kathleen Liu (University of California at San Francisco, United States). In this episode, Dr. Liu is joined by Dr. Kianoush Kashani (Mayo Clinic, United States) to discuss the rising importance of personalized care in AKI treatment. They delve into the world of digital health, exploring how digital decision support tools can empower clinicians and improve patient outcomes.
This episode will address:
Digital Health: Dr. Kashani breaks down the concept of digital health and its applications in the context o...
2024-03-2111 min
KDIGO Conversations in NephrologyEpisode 17: Stratifying the Risk of Persistent AKI and Clinical PracticeThis is the first episode in KDIGO's new 3-episode series on acute kidney injury (AKI), hosted by Dr. Kathleen Liu (University of California at San Francisco, United States). In this episode, Dr. Liu is joined by Dr. Jay Koyner (University of Chicago, United States) to discuss the emerging field of persistent acute kidney injury (AKI).
They delve into the question: what exactly is persistent AKI, and how does it differ from severe AKI? Dr. Liu and Dr. Koyner explore the key factors clinicians should consider when evaluating a patient's risk of developing persistent...
2024-03-2110 min
Medicina Familiar PodcastE25. Kdigo 2024 puntos clave para Medicina Familiar
En éste episodio hablo de la Kdigo 2024 y sus 20 puntos clave para
evaluación y manejo de IRC dedicado para médicos familiares, ¿será
que podemos aplicarlos?.
Gracias por la escucha. Si te gustó el episodio compártelo con tus
colegas, estudiantes y residentes.
---
Fuente:
KDIGO 2024
Top 10 Takeaways on Evaluation for Primary Care Physicians
https://kdigo.org/wp-content/uploads/2024/03/KDIGO-2024-CKD-Guideline-Top-10-Takeaways-for-PCPs-Evaluation.pdf
Top 10 Takeaways on Management for Primary Care Physicians
https://kdigo.org/wp...
2024-03-1819 minNefropapersEpisódio 76 - KDIGO Nefrite Lúpica 2024O KDIGO, organização internacional que produz guidelines em Nefrologia, começou 2024 já a todo vapor com a publicação da versão final do Guideline de Nefrite Lúpica, oficializando a versão que havia sido pré-publicada em março de 2023. Nesse episódio, Gabes e Fer fazem um resumo e análise dos principais pontos do guidelines, servindo de ótima revisão sobre as principais novidades que apareceram no tratamento do lúpus nos últimos anos
00:01 - 2:20 Introdução e Resumo do Episódio
02:21 - 06:10 Introdução KDIGO DE Nefrite Lúpica 2024
2024-02-0349 min
Clube Arretado | Medicina ArretadaEp. 2-5: Desmistificando a Injúria Renal AgudaNão fica injuriado se a creatinina subir. No quinto episódio dessa segunda temporada, discutimos sobre definições, classificações, além de como reconhecer e tratar a injúria renal aguda (anteriormente denominada lesão renal aguda).
Lojinha da Amazon (Livros e Materiais recomendados):
Episódio sobre Síndrome Nefrótica
Episódio sobre Distúrbios do Sódio
Episódio sobre Leptospirose e Síndromes Ictéricas Febris
Sigam e acompanhem a gente, nas redes:
Insta: @medicinarretada
Tiktok: @medicinarretada
Youtube: @medarretada
Site: https://medicinarretada.com.br/
E-mail: suporte@medicinarretada.com.br
Um "xêro" e até a próxima...
2024-01-0256 min
Medicina de impacto5x13. Actualización en enfermedad crónica: a propósito de las nuevas guías KDIGOEste pódcast está destinado exclusivamente a profesionales de la salud. Las guías KDIGO (Kidney Disease: Improving Global Outcomes) contienen un conjunto de recomendaciones clínicas con el objetivo principal de mejorar la atención de los pacientes y promover mejores resultados en términos de salud renal y calidad de vida. Las guías KDIGO para enfermedad renal crónica de 2023 son una actualización de las guías de 2012 para la evaluación y el manejo de esta afección. (Importante: se comentan las guías en revisión.) Notas: https://espanol.medscape.com/v...
2023-09-0835 minMedicina de impactoMedicina de impacto 13: 5×13. Actualización en enfermedad crónica: a propósito de las nuevas guías KDIGOEste pódcast está destinado exclusivamente a profesionales de la salud. Las guías KDIGO (Kidney Disease: Improving Global Outcomes) contienen un conjunto de recomendaciones clínicas con el objetivo principal de mejorar la atención de los pacientes y promover mejores resultados en términos de salud renal y calidad de vida. Las guías KDIGO para enfermedad renal crónica...
2023-09-0835 min
iForumRx.orgTop Ten Things Every Clinician Should Know About the KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney DiseaseThe Kidney Disease: Improving Global Outcomes (KDIGO) guidelines were recently updated with a focus on kidney health in patients with diabetes. The updated guidelines include recommendations on screening, prevention, and treatment of chronic kidney disease (CKD), including the use of SGLT2 inhibitors, finerenone, and ACE inhibitors or ARBs. The written commentary posted on the iForumRx website provides a succinct summary of the Top Ten Things Every Clinician Should Know.
Guest Authors: Kara Olstad, PharmD; Gurminder Sanghera, BSc, PharmD; and Darren Grabe, PharmD
Music by Good Talk
2023-07-2823 min
Medscape InDiscussion: Chronic Kidney DiseaseIs It Lupus Nephritis? A Path to Diagnosis and TreatmentJoin experts Drs Matt Sparks and Dawn Caster as they discuss the complexities around the management of lupus nephritis. What tools do we have now? What is on the horizon? Tune in to find out. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/991602). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals. Resources Novel Aspects in the Pathophysiology and Diagnosis of Glomerular Diseases https://pubmed.ncbi.nlm.nih.gov/36535746/ Derivation...
2023-07-2524 min
KDIGO Conversations in NephrologyEpisode 16: Appropriate CKD Referral to SpecialistsIn this episode, Dr. Peter Lin (Canadian Heart Research Centre, Canada) and Ikechi Okpechi (University of Alberta, Canada) discuss the right time to refer patients with CKD to a nephrologist. This episode also addresses rapid CKD progression and the utility of risk prediction equations.
This episode is supported by an independent educational grant from AstraZeneca.
2023-07-1116 min
KDIGO Conversations in NephrologyEpisode 15: Applying CKD InterventionsJoin host Dr. Peter Lin (Canadian Heart Research Centre, Canada) in conversation with Dr. Joel Topf (Oakland University, William Beaumont School of Medicine, USA) as they discuss how to combat CKD progression and the role of non-pharmacological vs pharmacological interventions. This episode will explore whether foundational therapies are underused and how to tailor the right treatment for the right patient at the right time.
This episode is supported by an independent educational grant from AstraZeneca.
2023-07-1115 min
KDIGO Conversations in NephrologyEpisode 14: CKD Evaluation & MeasurementIn this episode, Dr. Peter Lin (Canadian Heart Research Centre, Canada) and Dr. Magdalena Madero (National Heart Institute Mexico City, Mexico) discuss best practices for CKD evaluation and measurement. This episode focuses on the importance of assessing GFR and albuminuria, identifying the causes of CKD, CKD progression, and when more accurate GFR measures (such as cystatin) should be conducted.
This episode is supported by an independent educational grant from AstraZeneca.
2023-07-1116 min
KDIGO Conversations in NephrologyEpisode 13: Early Detection of CKDJoin host, Dr. Peter Lin (Canadian Heart Research Centre, Canada) and Dr. Lekha Tummalapalli (Weill Cornell Medicine, United States) as they discuss the importance of early CKD detection. This episode explores risk factors, screening for CKD, and country specific factors to take into account when screening for CKD.
This episode is supported by an independent educational grant from AstraZeneca.
Show Notes:
https://kdigo.org/conferences/early-identification/
https://www.theisn.org/blog/2023/05/22/new-quick-guide-to-early-ckd-identification-and-intervention-for-primary-care-settings-available-in-50-languages-by-year-end/
https://www.theisn.org/initiatives/ckd-early-screening-intervention/
2023-07-1109 minLife as a Nephrology ProfessionalGN Guidelines: 2021 NKF Kidney Disease Outcomes Quality Initiative Commentary (KDOQI)This episode explores the 2021 NKF Kidney Disease Outcomes Quality Initiative Commentary (KDOQI) on the Kidney Disease Improving Global Outcomes (KDIGO) guideline for glomerular diseases. The KDOQI commentary provides discussion on issues that are specific for implementation of the KDIGO guidelines in US healthcare settings. Tune in is as our host Dr. Natasha Dave dives into the commentary with Co-Chairs Dr. Bill Whittier, Rush University Medical Center in Chicago, and Dr. Laurence Beck, Boston Medical Center.
2023-06-201h 03
Channel Your EnthusiasmChapter Eleven: Regulation of Acid-Base Balance, part 2ReferencesWe considered the complexity of the machinery to excrete ammonium in the context of research on dietary protein and how high protein intake may increase glomerular pressure and contribute to progressive renal disease (many refer to this as the “Brenner hypothesis”). Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal diseaseA trial that studied low protein and progression of CKD The Effects of Dietary Protein Restriction and Blood-Pressure Control on the Prog...
2023-05-201h 30
Medscape InDiscussion: Type 2 DiabetesAdvances in Chronic Kidney Disease Care in Type 2 DiabetesJoin Dr Carol Wysham and Dr Katherine Tuttle as they discuss advances in kidney disease management in patients living with type 2 diabetes. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/982416). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals. Resources National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification https://pubmed.ncbi.nlm.nih.gov/12859163/ KDIGO 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease...
2023-03-0124 min
KDIGO Conversations in NephrologyEpisode 10: Challenges in the Early Diagnosis of AAVJoin host, Dr. Vladimir Tesar (General University Hospital, Prague), in conversation with Dr. Duvuru Geetha (Johns Hopkins University School of Medicine, United States) as they discuss the main causes of delays in diagnosis of ANCA-associated vasculitis and the different ways to increase awareness of the disease. This episode will also discuss the role of kidney biopsy in the optimal management and monitoring of these patients.
This episode is supported by Amgen.
2023-02-2212 min
KDIGO Conversations in NephrologyEpisode 11: Recent Progress in the Treatment of AAV and its Impact on the Outcome of the PatientsIn this episode, host Dr. Vladimir Tesar (General University Hospital, Prague) and Dr. David Jayne (Addenbrooke's Hospital, United Kingdom) discuss the roles of various agents in the induction and maintenance treatment of ANCA- associated vasculitis. They will explore the use of rituximab and complement inhibition in treating ANCA-associated vasculitis. This episode will address the gaps in knowledge and ongoing research in the field of ANCA-associated vasculitis.
This episode is supported by Amgen.
2023-02-2215 min
KDIGO Conversations in NephrologyEpisode 12: Is There Still Any Role for Plasma Exchange in AAV?In this episode, host Dr. Vladimir Tesar (General University Hospital, Prague) and Dr. Micheal Walsh (McMaster University, Canada) explore the benefits of plasma exchange for patients with ANCA-associated vasculitis. This episode discusses how to identify patients who may benefit from plasma exchange and the role of plasma exchange in patients with double-positive ANCA and anti-GBM. The utility of rituximab in those also treated with plasma exchange will be addressed.
This episode is supported by Amgen.
2023-02-2214 min
Nephrology Knowledge into Practice PodcastFSGS: KDIGO 2021 guideline | With Dr Richard GlassockIn 2021, a work group of international experts published an update to the 2012 iteration of this guideline. To do so they reviewed the latest evidence through a systematic literature review, with the aim of providing a useful resource for clinicians caring for individuals with glomerular disease through actionable recommendations.
In this episode we speak to Dr Richard Glassock, member of the work group, to hear his insights on the key takeaways from the guideline, and what has changed in this iteration.
By completing this activity you can qualify for 0.25 CME credits. To claim your credits, you...
2022-12-0514 min
KDIGO Conversations in NephrologyEpisode 9: Best Practices in Nutrition, Drug Management, and Multi-Organ Support in Patients with AKIJoin host, Dr. Marlies Ostermann (Guy's and St Thomas' Hospital, United Kingdom), in conversation with Dr. Sandra Kane-Gill (University of Pittsburgh School of Pharmacy, United States) as they discuss the importance of drug stewardship when treating critically ill patients. This episode will examine various terms such as drug-induced acute kidney injury, drug-associated acute kidney injury, and nephrotoxicity. Dr. Kane-Gill will also discuss how multiorgan support may influence drug dosing and aspects of nutrition and micronutrient supplementation for patients with AKI.
This episode is supported by an independent educational grant from Baxter.
2022-11-2116 min
KDIGO Conversations in NephrologyEpisode 8: The Role of Hemodynamics for AKI and Maintaining Hemodynamic Stability in KRT PatientsIn this episode, KDIGO Conversations in Nephrology host, Dr. Marlies Ostermann (Guy's and St Thomas' Hospital, United Kingdom), and Dr. Rinaldo Bellomo (University of Melbourne, Australia) will discuss the importance of hemodynamic stabilization in protecting kidney function for patients on kidney replacement therapy. This episode will also discuss the different strategies and therapies available for maintaining such stability. Urgent questions for future research will also be addressed.
This episode is supported by an independent educational grant from Baxter.
2022-11-2121 min
KDIGO Conversations in NephrologyEpisode 7: Best Practices in Fluid Management During CKRTJoin host, Dr. Marlies Ostermann (Guy's and St Thomas' Hospital, United Kingdom), in conversation with Dr. Javier Neyra (University of Alabama in Birmingham, United States) as they explore the role of kidney replacement therapy in managing fluid overload. They will discuss optimal monitoring and how best to remove fluid safely and effectively, including the evaluation of patients’ response to fluid removal prescription. This episode will also address the ongoing gaps in knowledge in the field.
This episode is supported by an independent educational grant from Baxter.
2022-11-2121 min
Ta de ClinicagemTdC 161: Doença Renal Crônica feat Layon Campagnaro do Nefropapershttps://www.tadeclinicagem.com.br/materiais/evento-org-dzero-na-residencia-2026/O começo do R1 de Clínica Médica pode ser desafiador. Mas você não precisa passar por isso sozinho(a).Descubra como tornar o R1 mais leve e produtivo com o D0 na Residência, evento on-line e gratuito do TdC.Garanta agora mesmo sua vaga e receba grátis no seu e-mail o Ebook: Sala de Emergência - Temas Essenciais.Do manejo de antibióticos à organização da rotina com IA, confira os temas que abordaremos ao vivo Sábado...
2022-11-0353 min
Diabetes Dialogue: Technology, Therapeutics, & Real-World PerspectivesDiabetes Dialogue: GLP-1 RA Shortage & ADA/KDIGO RecommendationsIn this episode of Diabetes Dialogue, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, discuss the ongoing GLP-1 RA shortage and whether or not celebrities using these agents for weight loss is a real issue in the community as well as provide insight into their top takeaways from the ADA/KDIGO consensus report.
2022-10-2429 minMedscape InDiscussion: Chronic Kidney DiseaseHow to Manage Chronic Kidney Disease in Primary CareWhat do primary care providers need to know to improve care for people with chronic kidney disease? Drs Matthew Sparks and Ian de Boer provide key clinical takeaways that can't be ignored. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/971885). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals. Resources KDIGO 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease https://www.kidney-international.org/article/S0085-2538(20)30718-3/fulltext ...
2022-08-1125 min
Nephrology Knowledge into Practice PodcastIgAN: Predicting risk and treatment response | With Dr Andrew BombackIgA nephropathy presents with a clinically diverse set of symptoms of wide-ranging severity and a varied disease course. As our understanding of IgA nephropathy has improved, various tools have been developed to help assess risk of progression to kidney failure.
This episode offers insight into the use of freely available tools that can assist with the management of IgA nephropathy. We are joined by Dr Andrew Bomback to discuss how these tools are applied in the clinic.
By completing this activity you can qualify for 0.25 CME credits. To claim your credits, you must listen to...
2022-06-0914 minMedscape InDiscussion: Type 2 DiabetesHow to Reduce Renal Risk in Type 2 DiabetesWant to prevent kidney disease progression in patients with type 2 diabetes? Join host Dr Silvio Inzucchi and nephrologist Dr David Cherney as they unpack the how and why behind current recommendations. Relevant disclosures can be found with the episode show notes on Medscape.com (https://www.medscape.com/viewarticle/963275). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals. Resources KDIGO 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease https://kdigo.org/wp-content/uploads/2020/10/KDIGO-2020-Diabetes-in-CKD-GL.pdf Introduction...
2022-04-1325 minNephrology Knowledge into Practice PodcastFSGS: Pathogenesis and pathophysiology | With Dr Sanjeev SethiWhile focal segmental glomerulosclerosis (FSGS) is rare overall, it is one of the most common glomerular diseases on Europe, North America and Latin America. Rather than being a specific disease entity, it is a pattern of injury that takes various forms that, together with the clinical presentation, have important implications for treatment and prognosis. Join Dr Sanjeev Sethi, pathologist at the Mayo Clinic, Rochester, Minnesota, USA, for an overview of our current understanding of how FSGS develops and presents.
By completing this module you can qualify for 0.25 CME credits. To claim your credits, you must listen to...
2022-03-0914 minNephrology Knowledge into Practice PodcastIgAN: Pathogenesis and pathophysiology | With Dr Richard LafayetteIgA nephropathy (IgAN) is a leading cause of chronic kidney disease and the most common glomerular disease worldwide. But its pathogenesis has not yet been fully elucidated, leaving some questions so far unanswered. Join Dr Richard Lafayette for an overview of our current understanding of how this disease develops and presents.
By completing this module you can qualify for 0.25 CME credits. To claim your credits, you must listen to the podcast and successfully pass the post-module assessment at nephrology.knowledgeintopractice.com, where you can find all past episodes of the podcast as well as other free CME...
2022-03-0114 min
Channel Your EnthusiasmChapter 6: Effects of Hormones on Renal Function part 2Chapter 6 part 2. ReferencesJosh touts the PARADIGM-HF Trial Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure | NEJM which found this combination was superior to an ARB alone Joel mentions an early atrial natriuretic peptide trial by Julie Lewis et al. Atrial natriuretic factor in oliguric acute renal failure - American Journal of Kidney Diseases and here’s a metanalysis that put this option to bed: Atrial Natriuretic Peptide for Management of Acute Kidney Injury: A Systematic Review and Meta-analysisSnack attack? Check out “Snack induced ANP” Snack-Induced Release of Atrial Natriuretic Factor...
2022-01-231h 52
KDIGO Conversations in NephrologyEpisode 6: Management of DyskalemiasJoin KDIGO Conversations in Nephrology host, Dr. Roberto Pecoits-Filho, in conversation with Dr. Chuck Herzog as they explore the challenges that occur when managing dyskalemia. They address the consequences of hyperkalemia and hypokalemia. They also discuss how both hospitalized patients and outpatients are affected by hyperkalemia.
Dr. Roberto Pecoits-Filho is Senior Research Scientist at Arbor Research and Professor of Medicine at the Pontifical Catholic University of Paraná.
Dr. Chuck Herzog is Professor of Medicine at the University of Minnesota, and a cardiologist at Hennepin County Medical Center.
This episode was supported by CSL Vifor.
2021-09-3020 min
KDIGO Conversations in NephrologyEpisode 5: Approaches to RASi OptimizationJoin KDIGO Conversations in Nephrology host, Dr. Roberto Pecoits-Filho, in conversation with Dr. Patrick Rossignol as they discuss approaches to RASi optimization. Additional topics include:
Monitoring of creatinine and potassium
What happens after? Is the GP responsible for follow-up?
When to discontinue, when to return?
Lack of communication between specialties
How different specialties react differently to different values
Dr. Roberto Pecoits-Filho is a nephrologist and Senior Research Scientist at Arbor Research and Professor of Medicine at the Pontifical Catholic University of Paraná.
Dr. Patrick Rossignol is a Professor of Therapeutics, a nephrology and vascular medicine specialist, and head of Nancy Plu...
2021-09-2912 min
KDIGO Conversations in NephrologyEpisode 4: Benefits of RASi UtilizationJoin host, Dr. Roberto Pecoits-Filho, and Dr. Catherine Clase as they discuss the benefits of RASi utilization. Additional topics include:
The role of RASi in the management of CKD progression
Outcomes
ACE / ARBs
Is RASi underutilized? Is it worth not to discontinue?
The impact of the KDIGO Blood Pressure Management in CKD Guideline and Diabetes Management in CKD Guideline on RAASi utilization and future challenges
Dr. Roberto Pecoits-Filho is Senior Research Scientist at Arbor Research and Professor of Medicine at the Pontifical Catholic University of Paraná,
Dr. Catherine Clase is a nephrologist and Professor of Medicine at McMaster University and Edit...
2021-09-2921 min
Global Kidney Care Podcast Provided by ISNSeason 2 Episode 1: Early Identification and Intervention of Chronic Kidney Disease (KDIGO) – a Toolkit with an eye on primary care settingsRoberto and Smeeta are joined Michael G. Shlipak, MD from the University of California San Francisco and Sri Lekha Tummalapalli, MD, MBA from Weill Cornell Medicine to discuss their representation at the KDIGO Controversies Conference and its resulting ISN-KDIGO Chronic Kidney Disease (CKD) Early Identification and Intervention Toolkit, which offers a series of tools for CKD early identification and intervention aimed at kidney health professionals, primary care physicians and nurses working in primary care settings. Dr. Tummalapali and Shlipak discuss current screening recommendations, testing, treatments and how can nephrologists and other specialities prevent CKD and delay complications for those w...
2021-08-2433 min
KDIGO Conversations in NephrologyEpisode 3: How to Develop an Acute Dialysis Care Quality Program - Quality Metrics and Continuous ImprovementDr. Ravi Mehta and Theresa Mottes discuss which key components are needed when starting a quality improvement program (QI) for acute dialysis and why those components are needed. They also discuss how to get leverage to implement a QI program and the keys to a successful CRRT quality program.
This episode was supported by Baxter.
2021-08-1012 min
KDIGO Conversations in NephrologyEpisode 2: Maximizing Filter Life During CRRT – Best Practices on Anticoagulation and Citrate UseDr. Ravi Mehta and Dr. Ashita Tolwani discuss best practices on anticoagulation and citrate use, why circuit patency and integrity are important for CRRT, and how and when to use anticoagulation. They also discuss preferred methods for anticoagulation and the parameters that should be monitored for circuit integrity.
This episode was supported by Baxter.
2021-08-1015 min
KDIGO Conversations in NephrologyEpisode 1: Deciding When and Who Should Start Acute Dialysis - From Evidence to Bedside PracticeIn this episode, Dr. Ravi Mehta and Dr. Marlies Ostermann discuss the controversy around defining the optimal timing for starting dialysis in critically ill patients. Dr. Osterman highlights the most relevant parameters that influence when to offer, start, and stop dialysis and gives a comprehensive review of the recent trials on the timing of dialysis. And finally, both presenters address the challenges of managing patients during the COVID-19 pandemic.
This episode was supported by Baxter.
2021-08-1013 min
にゃんごう＆いがさんのEBMerな夜No.54：健康アプリとKDIGO CKD血圧管理診療ガイドライン2021にゃんごう＆いがさんのEBMerな夜
第54回放送 2021/6/26
【いがさん：健康アプリ】
Tangari G, Ikram M, Ijaz K, Kaafar MA, Berkovsky S.
Mobile health and privacy: cross sectional study.
BMJ. 2021 Jun 16;373:n1248. doi: 10.1136/bmj.n1248.
PMID: 34135009.
https://www.bmj.com/content/373/bmj.n1248
【にゃんごう：KDIGO CKD血圧管理診療ガイドライン2021】
Tomson CRV, Cheung AK, Mann JFE, Chang TI, Cushman WC, Furth SL, Hou FF, Knoll GA, Muntner P, Pecoits-Filho R, Tobe SW, Lytvyn L, Craig JC, Tunnicliffe DJ, Howell M, Tonelli M, Cheung M, Earley A, Ix JH, Sarnak MJ.
Management of Blood Pressure in Patients With Chronic Kidney Disease Not Receiving...
2021-06-2631 min
CorConsult Rx: Evidence-Based Medicine and Pharmacy2021 KDIGO Update: Managing Hypertension in CKDOn this episode we review the 2021 KDIGO Guidelines on Managing blood pressure in a patient with CKD. You can read the Executive summary at the link below: Thanks for listening! If you want to support the podcast, check out our Patreon account. Subscribers will have access to all previous and new pharmacotherapy lectures as well as downloadable Power Point slides for each lecture. You can find our account at the website below: If you have any questions for Cole or me, reach out to us on any of the following: Text - 415-943-6116 Mike - mcorvino@corconsultrx.com Cole...
2021-04-2043 minCorConsult Rx: Evidence-Based Medicine and Pharmacy2021 KDIGO Update: Managing Hypertension in CKDOn this episode we review the 2021 KDIGO Guidelines on Managing blood pressure in a patient with CKD. You can read the Executive summary at the link below: Thanks for listening! If you want to support the podcast, check out our Patreon account. Subscribers will have access to all previous and new pharmacotherapy lectures as well as downloadable Power Point slides for each lecture. You can find our account at the website below: If you have any questions for Cole or me, reach out to us on any of the following: Text - 415-943-6116 Mike - mcorvino@corconsultrx.com Cole...
2021-04-2043 min
CorConsult Rx: Evidence-Based Medicine and Pharmacy2021 KDIGO Update: Managing Hypertension in CKDOn this episode we review the 2021 KDIGO Guidelines on Managing blood pressure in a patient with CKD. You can read the Executive summary at the link below: https://www.kidney-international.org/article/S0085-2538(20)31269-2/fulltext Thanks for listening! If you want to support the podcast, check out our Patreon account. Subscribers will have access to all previous and new pharmacotherapy lectures as well as downloadable Power Point slides for each lecture. You can find our account at the website below: www.patreon.com/corconsultrx If you have any questions for C...
2021-04-2043 min
Ambulatory Care PodcastReview of 2020 KDIGO Clinical Practice Guideline for Diabetes Management in CKDA review of the updated guidance from KDIGO regarding the management of diabetes in the setting of chronic kidney disease. This podcast addresses highlights of the update and attempts to provide FAQ clinicians encounter when attempting to apply this guidance in practice. Recorded by Jen Slaughter, PharmD, BCACPPrimary Care Clinical PharmacistSSM Health
2021-03-1714 min
Emergency Medicine IrelandTasty Morsels of Critical Care 015 | Acute Kidney InjuryWelcome back to the tasty morsels of critical care podcast.
This is a somewhat basic and general episode, even for this podcast which indulges in frequent generalisation and summaries of pre existing summaries.
It covers Oh’s Manual Chapter 47 looking at Acute Kidney Injury. While hardly the most exciting topic in the world, there a few important pearls here perhaps worth emphasising.
Oh leads with KDIGO as the AKI classification of choice. The KDIGO classification splits you into 3 stages based on changes in creatinine and urine output over specified time periods. When you co...
2020-12-2403 min
Physician Assistant IN Education (PAINE) PodcastEpisode #64 - KDIGO Guidelines for CKDI haven’t done much during the 2 week block for GU and renal, but I do teach the nephrology section at my program. So for this podcast, I thought I would review the KDIGO/KDOQI guidelines for evaluation and management of CKD.
2020-09-1726 min
Ta de ClinicagemEpisódio 38 - Lesão Renal Aguda no Paciente Internadohttps://www.tadeclinicagem.com.br/materiais/evento-org-dzero-na-residencia-2026/O começo do R1 de Clínica Médica pode ser desafiador. Mas você não precisa passar por isso sozinho(a).Descubra como tornar o R1 mais leve e produtivo com o D0 na Residência, evento on-line e gratuito do TdC.Garanta agora mesmo sua vaga e receba grátis no seu e-mail o Ebook: Sala de Emergência - Temas Essenciais.Do manejo de antibióticos à organização da rotina com IA, confira os temas que abordaremos ao vivo Sábado...
2020-05-0750 min
Freely Filtered, a NephJC PodcastDeep Mind predicts AKICast:Joel TopfSamira FaroukJennie LinSwapnil Hiremathand special guest, Perry WilsonA clinically applicable approach to continuous prediction of future acute kidney injury. https://www.ncbi.nlm.nih.gov/pubmed/?term=A+clinically+applicable+approach+to+continuous+prediction+of+future+acute+kidney+injury#Deep Mind National Health services scandal https://www.telegraph.co.uk/technology/2017/07/03/googles-deepmind-nhs-misused-patient-data-trial-watchdog-says/KDIGO AKI guidelines (PDF) https://kdigo.org/wp-content/uploads/2016/10/KDIGO-2012-AKI-Guideline-English.pdfFrank Harrell on...
2019-10-1455 min
Freely Filtered, a NephJC PodcastMENTOR: Rituximab vs Cyclosporin in Idiopathic MembranousCast:Joel TopfJennie LinSwapnil HiremathMatt SparksShow Notes:NephJC Coverage of MENTOR: http://www.nephjc.com/news/mentorMENTOR: https://www.nejm.org/doi/full/10.1056/NEJMoa1814427KDIGO Membranous recommendations: https://kdigo.org/wp-content/uploads/2017/02/KDIGO-2012-GN-Guideline-English.pdf2017 Kidney Week Abstract: https://www.asn-online.org/education/kidneyweek/2017/program-abstract.aspx?controlId=2831149PEXIVAS: http://www.nephjc.com/news/pexivasearlyHeymann Nephritis: https://www.ncbi.nlm.nih.gov/pmc/articles...
2019-08-181h 01